Profiles

Keywords
Last Name
Institution

Paul Carvey

TitleProfessor
InstitutionRush University, Rush Medical College
DepartmentPhysiology and Biophysics
Address1750 West Harrison St
Chicago IL 60612
vCardDownload vCard

    Collapse Overview 
    Collapse overview
    Dean Emeritus, the Graduate College
    Professor, Department of Physiology & Biophysics, Rush Medical College

    Research Areas:
    Parkinson’s disease, dopamine systems in the brain.

    My Scopus ID is 7005354230.
    My NIH COMMONS name is CARVEY.

    My Faculty Profile at Rush University Medical Center:
    https://www.rushu.rush.edu/faculty/paul-m-carvey-phd

    My NCBI Bibliography:
    https://www.ncbi.nlm.nih.gov/pubmed/?term=Carvey+PM

    My Scopus:
    https://www.scopus.com/authid/detail.uri?authorId=7005354230

    Education:
    PhD, Rush University
    MS, Creighton University
    BS, Creighton University


    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Kousik SM, Napier TC, Ross RD, Sumner DR, Carvey PM. Dopamine receptors and the persistent neurovascular dysregulation induced by methamphetamine self-administration in rats. J Pharmacol Exp Ther. 2014 Nov; 351(2):432-9. PMID: 25185214.
      View in: PubMed
    2. Kousik SM, Carvey PM, Napier TC. Methamphetamine self-administration results in persistent dopaminergic pathology: implications for Parkinson's disease risk and reward-seeking. Eur J Neurosci. 2014 Aug; 40(4):2707-14. PMID: 24890790.
      View in: PubMed
    3. Kelly LP, Carvey PM, Keshavarzian A, Shannon KM, Shaikh M, Bakay RA, Kordower JH. Progression of intestinal permeability changes and alpha-synuclein expression in a mouse model of Parkinson's disease. Mov Disord. 2014 Jul; 29(8):999-1009. PMID: 24898698.
      View in: PubMed
    4. Kousik SM, Napier TC, Carvey PM. The effects of psychostimulant drugs on blood brain barrier function and neuroinflammation. Front Pharmacol. 2012; 3:121. PMID: 22754527.
      View in: PubMed
    5. Kousik SM, Graves SM, Napier TC, Zhao C, Carvey PM. Methamphetamine-induced vascular changes lead to striatal hypoxia and dopamine reduction. Neuroreport. 2011 Dec 07; 22(17):923-8. PMID: 21979424.
      View in: PubMed
    6. Desai Bradaric B, Patel A, Schneider JA, Carvey PM, Hendey B. Evidence for angiogenesis in Parkinson's disease, incidental Lewy body disease, and progressive supranuclear palsy. J Neural Transm (Vienna). 2012 Jan; 119(1):59-71. PMID: 21748523.
      View in: PubMed
    7. Patel A, Toia GV, Colletta K, Bradaric BD, Carvey PM, Hendey B. An angiogenic inhibitor, cyclic RGDfV, attenuates MPTP-induced dopamine neuron toxicity. Exp Neurol. 2011 Sep; 231(1):160-70. PMID: 21703263.
      View in: PubMed
    8. Carvey PM, Hendey B, Monahan AJ. The blood-brain barrier in neurodegenerative disease: a rhetorical perspective. J Neurochem. 2009 Oct; 111(2):291-314. PMID: 19659460.
      View in: PubMed
    9. Desai BS, Schneider JA, Li JL, Carvey PM, Hendey B. Evidence of angiogenic vessels in Alzheimer's disease. J Neural Transm (Vienna). 2009 May; 116(5):587-97. PMID: 19370387.
      View in: PubMed
    10. Wang S, Yan JY, Lo YK, Carvey PM, Ling Z. Dopaminergic and serotoninergic deficiencies in young adult rats prenatally exposed to the bacterial lipopolysaccharide. Brain Res. 2009 Apr 10; 1265:196-204. PMID: 19236855.
      View in: PubMed
    11. Ling Z, Zhu Y, Tong CW, Snyder JA, Lipton JW, Carvey PM. Prenatal lipopolysaccharide does not accelerate progressive dopamine neuron loss in the rat as a result of normal aging. Exp Neurol. 2009 Apr; 216(2):312-20. PMID: 19133261.
      View in: PubMed
    12. Bronstein J, Carvey P, Chen H, Cory-Slechta D, DiMonte D, Duda J, English P, Goldman S, Grate S, Hansen J, Hoppin J, Jewell S, Kamel F, Koroshetz W, Langston JW, Logroscino G, Nelson L, Ravina B, Rocca W, Ross GW, Schettler T, Schwarzschild M, Scott B, Seegal R, Singleton A, Steenland K, Tanner CM, Van Den Eeden S, Weisskopf M. Meeting report: consensus statement-Parkinson's disease and the environment: collaborative on health and the environment and Parkinson's Action Network (CHE PAN) conference 26-28 June 2007. Environ Health Perspect. 2009 Jan; 117(1):117-21. PMID: 19165397.
      View in: PubMed
    13. Monahan AJ, Warren M, Carvey PM. Neuroinflammation and peripheral immune infiltration in Parkinson's disease: an autoimmune hypothesis. Cell Transplant. 2008; 17(4):363-72. PMID: 18522239.
      View in: PubMed
    14. Zhao C, Ling Z, Newman MB, Bhatia A, Carvey PM. TNF-alpha knockout and minocycline treatment attenuates blood-brain barrier leakage in MPTP-treated mice. Neurobiol Dis. 2007 Apr; 26(1):36-46. PMID: 17234424.
      View in: PubMed
    15. Zhu Y, Carvey PM, Ling Z. Altered glutathione homeostasis in animals prenatally exposed to lipopolysaccharide. Neurochem Int. 2007 Mar; 50(4):671-80. PMID: 17291629.
      View in: PubMed
    16. Desai BS, Monahan AJ, Carvey PM, Hendey B. Blood-brain barrier pathology in Alzheimer's and Parkinson's disease: implications for drug therapy. Cell Transplant. 2007; 16(3):285-99. PMID: 17503739.
      View in: PubMed
    17. Zhu Y, Carvey PM, Ling Z. Age-related changes in glutathione and glutathione-related enzymes in rat brain. Brain Res. 2006 May 23; 1090(1):35-44. PMID: 16647047.
      View in: PubMed
    18. Ling Z, Zhu Y, Tong Cw, Snyder JA, Lipton JW, Carvey PM. Progressive dopamine neuron loss following supra-nigral lipopolysaccharide (LPS) infusion into rats exposed to LPS prenatally. Exp Neurol. 2006 Jun; 199(2):499-512. PMID: 16504177.
      View in: PubMed
    19. Carvey PM, Punati A, Newman MB. Progressive dopamine neuron loss in Parkinson's disease: the multiple hit hypothesis. Cell Transplant. 2006; 15(3):239-50. PMID: 16719059.
      View in: PubMed
    20. Carvey PM, Zhao CH, Hendey B, Lum H, Trachtenberg J, Desai BS, Snyder J, Zhu YG, Ling ZD. 6-Hydroxydopamine-induced alterations in blood-brain barrier permeability. Eur J Neurosci. 2005 Sep; 22(5):1158-68. PMID: 16176358.
      View in: PubMed
    21. Chen L, Cagniard B, Mathews T, Jones S, Koh HC, Ding Y, Carvey PM, Ling Z, Kang UJ, Zhuang X. Age-dependent motor deficits and dopaminergic dysfunction in DJ-1 null mice. J Biol Chem. 2005 Jun 03; 280(22):21418-26. PMID: 15799973.
      View in: PubMed
    22. Collier TJ, Dung Ling Z, Carvey PM, Fletcher-Turner A, Yurek DM, Sladek JR, Kordower JH. Striatal trophic factor activity in aging monkeys with unilateral MPTP-induced parkinsonism. Exp Neurol. 2005 Feb; 191 Suppl 1:S60-7. PMID: 15629762.
      View in: PubMed
    23. Carvey PM, Chen EY, Lipton JW, Tong CW, Chang QA, Ling ZD. Intra-parenchymal injection of tumor necrosis factor-alpha and interleukin 1-beta produces dopamine neuron loss in the rat. J Neural Transm (Vienna). 2005 May; 112(5):601-12. PMID: 15583962.
      View in: PubMed
    24. Ling Z, Chang QA, Tong CW, Leurgans SE, Lipton JW, Carvey PM. Rotenone potentiates dopamine neuron loss in animals exposed to lipopolysaccharide prenatally. Exp Neurol. 2004 Dec; 190(2):373-83. PMID: 15530876.
      View in: PubMed
    25. Ling ZD, Chang Q, Lipton JW, Tong CW, Landers TM, Carvey PM. Combined toxicity of prenatal bacterial endotoxin exposure and postnatal 6-hydroxydopamine in the adult rat midbrain. Neuroscience. 2004; 124(3):619-28. PMID: 14980732.
      View in: PubMed
    26. Carvey PM, Chang Q, Lipton JW, Ling Z. Prenatal exposure to the bacteriotoxin lipopolysaccharide leads to long-term losses of dopamine neurons in offspring: a potential, new model of Parkinson's disease. Front Biosci. 2003 Sep 01; 8:s826-37. PMID: 12957870.
      View in: PubMed
    27. Kompoliti K, Adler CH, Raman R, Pincus JH, Leibowitz MT, Ferry JJ, Blasucci L, Caviness JN, Leurgans S, Chase WM, Yones LC, Tan E, Carvey P, Goetz CG. Gender and pramipexole effects on levodopa pharmacokinetics and pharmacodynamics. Neurology. 2002 May 14; 58(9):1418-22. PMID: 12011296.
      View in: PubMed
    28. Lipton JW, Vu TQ, Ling Z, Gyawali S, Mayer JR, Carvey PM. Prenatal cocaine exposure induces an attenuation of uterine blood flow in the rat. Neurotoxicol Teratol. 2002 Mar-Apr; 24(2):143-8. PMID: 11943502.
      View in: PubMed
    29. Gayle DA, Ling Z, Tong C, Landers T, Lipton JW, Carvey PM. Lipopolysaccharide (LPS)-induced dopamine cell loss in culture: roles of tumor necrosis factor-alpha, interleukin-1beta, and nitric oxide. Brain Res Dev Brain Res. 2002 Jan 31; 133(1):27-35. PMID: 11850061.
      View in: PubMed
    30. Goetz CG, Carvey PM, Pappert EJ, Vu TQ, Leurgans SE. The role of the serotonin system in animal models of myoclonus. Adv Neurol. 2002; 89:244-8. PMID: 11968451.
      View in: PubMed
    31. Ling Z, Gayle DA, Ma SY, Lipton JW, Tong CW, Hong JS, Carvey PM. In utero bacterial endotoxin exposure causes loss of tyrosine hydroxylase neurons in the postnatal rat midbrain. Mov Disord. 2002 Jan; 17(1):116-24. PMID: 11835448.
      View in: PubMed
    32. Carvey PM, Ling ZD, Sortwell CE, Pitzer MR, McGuire SO, Storch A, Collier TJ. A clonal line of mesencephalic progenitor cells converted to dopamine neurons by hematopoietic cytokines: a source of cells for transplantation in Parkinson's disease. Exp Neurol. 2001 Sep; 171(1):98-108. PMID: 11520124.
      View in: PubMed
    33. Storch A, Paul G, Csete M, Boehm BO, Carvey PM, Kupsch A, Schwarz J. Long-term proliferation and dopaminergic differentiation of human mesencephalic neural precursor cells. Exp Neurol. 2001 Aug; 170(2):317-25. PMID: 11476598.
      View in: PubMed
    34. Carvey PM, McGuire SO, Ling ZD. Neuroprotective effects of D3 dopamine receptor agonists. Parkinsonism Relat Disord. 2001 Jul; 7(3):213-223. PMID: 11331189.
      View in: PubMed
    35. McGuire SO, Ling ZD, Lipton JW, Sortwell CE, Collier TJ, Carvey PM. Tumor necrosis factor alpha is toxic to embryonic mesencephalic dopamine neurons. Exp Neurol. 2001 Jun; 169(2):219-30. PMID: 11358437.
      View in: PubMed
    36. Chen S, Carvey P. Validation of liquid-liquid extraction followed by flow-injection negative ion electrospray mass spectrometry assay to Topiramate in human plasma. Rapid Commun Mass Spectrom. 2001; 15(2):159-63. PMID: 11180545.
      View in: PubMed
    37. Kompoliti K, Goetz CG, Vu TQ, Carvey PM, Leurgans S, Raman R. Estrogen supplementation in the posthypoxic myoclonus rat model. Clin Neuropharmacol. 2001 Jan-Feb; 24(1):58-61. PMID: 11290883.
      View in: PubMed
    38. Kordower JH, Emborg ME, Bloch J, Ma SY, Chu Y, Leventhal L, McBride J, Chen EY, Palfi S, Roitberg BZ, Brown WD, Holden JE, Pyzalski R, Taylor MD, Carvey P, Ling Z, Trono D, Hantraye P, Déglon N, Aebischer P. Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease. Science. 2000 Oct 27; 290(5492):767-73. PMID: 11052933.
      View in: PubMed
    39. Storch A, Blessing H, Bareiss M, Jankowski S, Ling ZD, Carvey P, Schwarz J. Catechol-O-methyltransferase inhibition attenuates levodopa toxicity in mesencephalic dopamine neurons. Mol Pharmacol. 2000 Mar; 57(3):589-94. PMID: 10692500.
      View in: PubMed
    40. Ling ZD, Collier TJ, Sortwell CE, Lipton JW, Vu TQ, Robie HC, Carvey PM. Striatal trophic activity is reduced in the aged rat brain. Brain Res. 2000 Feb 21; 856(1-2):301-9. PMID: 10677639.
      View in: PubMed
    41. Goetz CG, Vu TQ, Carvey PM, Leurgans S. Posthypoxic myoclonus in the rat: natural history, stability, and serotonergic influences. Mov Disord. 2000; 15 Suppl 1:39-46. PMID: 10755271.
      View in: PubMed
    42. Vu TQ, Ling ZD, Ma SY, Robie HC, Tong CW, Chen EY, Lipton JW, Carvey PM. Pramipexole attenuates the dopaminergic cell loss induced by intraventricular 6-hydroxydopamine. J Neural Transm (Vienna). 2000; 107(2):159-76. PMID: 10847557.
      View in: PubMed
    43. Lipton JW, Ling Z, Vu TQ, Robie HC, Mangan KP, Weese-Mayer DE, Carvey PM. Prenatal cocaine exposure reduces glial cell line-derived neurotrophic factor (GDNF) in the striatum and the carotid body of the rat: implications for DA neurodevelopment. Brain Res Dev Brain Res. 1999 Dec 10; 118(1-2):231-5. PMID: 10611525.
      View in: PubMed
    44. Potter ED, Ling ZD, Carvey PM. Cytokine-induced conversion of mesencephalic-derived progenitor cells into dopamine neurons. Cell Tissue Res. 1999 May; 296(2):235-46. PMID: 10382268.
      View in: PubMed
    45. Ling ZD, Robie HC, Tong CW, Carvey PM. Both the antioxidant and D3 agonist actions of pramipexole mediate its neuroprotective actions in mesencephalic cultures. J Pharmacol Exp Ther. 1999 Apr; 289(1):202-10. PMID: 10087005.
      View in: PubMed
    46. Dodel RC, Du Y, Bales KR, Ling Z, Carvey PM, Paul SM. Caspase-3-like proteases and 6-hydroxydopamine induced neuronal cell death. Brain Res Mol Brain Res. 1999 Jan 22; 64(1):141-8. PMID: 9889353.
      View in: PubMed
    47. Pappert EJ, Goetz CG, Vu TQ, Ling ZD, Leurgans S, Raman R, Carvey PM. Animal model of posthypoxic myoclonus: effects of serotonergic antagonists. Neurology. 1999 Jan 01; 52(1):16-21. PMID: 9921842.
      View in: PubMed
    48. Chen S, Li Q, Carvey PM, Li K. Analysis of 9-fluorenylmethyloxycarbonyl derivatives of catecholamines by high performance liquid chromatography, liquid chromatography/mass spectrometry and tandem mass spectrometry. Rapid Commun Mass Spectrom. 1999; 13(18):1869-77. PMID: 10482902.
      View in: PubMed
    49. Chen S, Carvey PM. Rapid approach to the quantitative determination of topiramate (2, 3:4,5-bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate) in human plasma by liquid-liquid extraction and flow-injection negative-ion electrospray mass spectrometry. Rapid Commun Mass Spectrom. 1999; 13(20):1980-4. PMID: 10510408.
      View in: PubMed
    50. Dodel RC, Du Y, Bales KR, Ling ZD, Carvey PM, Paul SM. Peptide inhibitors of caspase-3-like proteases attenuate 1-methyl-4-phenylpyridinum-induced toxicity of cultured fetal rat mesencephalic dopamine neurons. Neuroscience. 1998 Oct; 86(3):701-7. PMID: 9692710.
      View in: PubMed
    51. Lipton JW, Robie HC, Ling Z, Weese-Mayer DE, Carvey PM. The magnitude of brain dopamine depletion from prenatal cocaine exposure is a function of uterine position. Neurotoxicol Teratol. 1998 Jul-Aug; 20(4):373-82. PMID: 9697963.
      View in: PubMed
    52. Lipton JW, Robie HS, Ling Z, Weese-Mayer DE, Carvey PM. Uterine position determines the extent of dopamine reduction after chronic prenatal cocaine exposure. Ann N Y Acad Sci. 1998 May 30; 844:314-23. PMID: 9668689.
      View in: PubMed
    53. Lipton JW, Robie HS, Ling Z, Weese-Mayer DE, Carvey PM. Uterine Position Determines the Extent of Dopamine Reduction after Chronic Prenatal Cocaine Exposure. Ann N Y Acad Sci. 1998 May; 844(1):314-323. PMID: 29090821.
      View in: PubMed
    54. Ling ZD, Tong CW, Carvey PM. Partial purification of a pramipexole-induced trophic activity directed at dopamine neurons in ventral mesencephalic cultures. Brain Res. 1998 Apr 27; 791(1-2):137-45. PMID: 9593863.
      View in: PubMed
    55. Pappert EJ, Goetz CG, Stebbins GT, Belden M, Carvey PM. 5-Hydroxytryptophan-induced myoclonus in guinea pigs: mediation through 5-HT1/2 receptor subtypes. Eur J Pharmacol. 1998 Apr 17; 347(1):51-6. PMID: 9650847.
      View in: PubMed
    56. Goetz CG, Pappert EJ, Blasucci LM, Stebbins GT, Ling ZD, Nora MV, Carvey PM. Intravenous levodopa in hallucinating Parkinson's disease patients: high-dose challenge does not precipitate hallucinations. Neurology. 1998 Feb; 50(2):515-7. PMID: 9484386.
      View in: PubMed
    57. Ling ZD, Potter ED, Lipton JW, Carvey PM. Differentiation of mesencephalic progenitor cells into dopaminergic neurons by cytokines. Exp Neurol. 1998 Feb; 149(2):411-23. PMID: 9500954.
      View in: PubMed
    58. Pappert EJ, Lipton JW, Goetz CG, Ling ZD, Stebbins GT, Carvey PM. The stability of carbidopa in solution. Mov Disord. 1997 Jul; 12(4):608-10. PMID: 9251084.
      View in: PubMed
    59. Thajeb P, Ling ZD, Potter ED, Carvey PM. The effects of storage conditions and trophic supplementation on the survival of fetal mesencephalic cells. Cell Transplant. 1997 May-Jun; 6(3):297-307. PMID: 9171162.
      View in: PubMed
    60. Carvey PM, Pieri S, Ling ZD. Attenuation of levodopa-induced toxicity in mesencephalic cultures by pramipexole. J Neural Transm (Vienna). 1997; 104(2-3):209-28. PMID: 9203083.
      View in: PubMed
    61. Vawter MP, Dillon-Carter O, Tourtellotte WW, Carvey P, Freed WJ. TGFbeta1 and TGFbeta2 concentrations are elevated in Parkinson's disease in ventricular cerebrospinal fluid. Exp Neurol. 1996 Dec; 142(2):313-22. PMID: 8934562.
      View in: PubMed
    62. Pappert EJ, Goetz CG, Niederman F, Ling ZD, Stebbins GT, Carvey PM. Liquid levodopa/carbidopa produces significant improvement in motor function without dyskinesia exacerbation. Neurology. 1996 Dec; 47(6):1493-5. PMID: 8960733.
      View in: PubMed
    63. Lipton JW, Davidson TL, Carvey PM, Weese-Mayer DE. Prenatal cocaine: effect on hypoxic ventilatory responsiveness in neonatal rats. Respir Physiol. 1996 Nov; 106(2):161-9. PMID: 8971989.
      View in: PubMed
    64. Pappert EJ, Tangney CC, Goetz CG, Ling ZD, Lipton JW, Stebbins GT, Carvey PM. Alpha-tocopherol in the ventricular cerebrospinal fluid of Parkinson's disease patients: dose-response study and correlations with plasma levels. Neurology. 1996 Oct; 47(4):1037-42. PMID: 8857741.
      View in: PubMed
    65. Ling ZD, Pieri SC, Carvey PM. Comparison of the neurotoxicity of dihydroxyphenylalanine stereoisomers in cultured dopamine neurons. Clin Neuropharmacol. 1996 Aug; 19(4):360-5. PMID: 8829000.
      View in: PubMed
    66. Carvey PM, Lin DH, Faselis CJ, Notermann JK, Ling ZD. Loss of striatal DA innervation increases striatal trophic activity directed at DA neurons in culture. Exp Neurol. 1996 Aug; 140(2):184-97. PMID: 8690061.
      View in: PubMed
    67. Lipton JW, Yuengsrigul A, Ling ZD, Weese-Mayer DE, Carvey PM. Prenatal cocaine exposure and postnatal hypoxia independently decrease carotid body dopamine in neonatal rats. Neurotoxicol Teratol. 1996 May-Jun; 18(3):283-7. PMID: 8725640.
      View in: PubMed
    68. Pappert EJ, Buhrfiend C, Lipton JW, Carvey PM, Stebbins GT, Goetz CG. Levodopa stability in solution: time course, environmental effects, and practical recommendations for clinical use. Mov Disord. 1996 Jan; 11(1):24-6. PMID: 8771063.
      View in: PubMed
    69. Hedges S, El-Mallakh RS, Carvey PM, Suddath RL, Wyatt RJ. Dopamine-responsive neurotrophic factor in schizophrenia. Schizophr Res. 1995 Dec; 18(1):83-4. PMID: 8929765.
      View in: PubMed
    70. Ptak LR, Hart KR, Lin D, Carvey PM. Isolation and manipulation of rostral mesencephalic tegmental progenitor cells from rat. Cell Transplant. 1995 May-Jun; 4(3):335-42. PMID: 7640873.
      View in: PubMed
    71. Yu SJ, Lo ES, Cochran EJ, Lin DH, Faselis CJ, Klawans HL, Carvey PM. Cerebrospinal fluid from patients with Parkinson's disease alters the survival of dopamine neurons in mesencephalic culture. Exp Neurol. 1994 Mar; 126(1):15-24. PMID: 7908885.
      View in: PubMed
    72. Weese-Mayer DE, Silvestri JM, Lin D, Buhrfiend CM, Ptak LR, Lo ES, Carvey PM. Hypoxia after prenatal cocaine attenuates striatal dopamine and neurotrophic activity. Neurotoxicol Teratol. 1994 Mar-Apr; 16(2):177-81. PMID: 8052192.
      View in: PubMed
    73. Carvey PM, Ptak LR, Lin D, Lo ES, Buhrfiend CM, Drucker GE, Fields JZ. Alterations in striatal neurotrophic activity induced by dopaminergic drugs. Pharmacol Biochem Behav. 1993 Sep; 46(1):195-204. PMID: 7902982.
      View in: PubMed
    74. Weese-Mayer DE, Silvestri JM, Lin D, Buhrfiend CM, Lo ES, Carvey PM. Effect of cocaine in early gestation on striatal dopamine and neurotrophic activity. Pediatr Res. 1993 Sep; 34(3):389-92. PMID: 8134184.
      View in: PubMed
    75. Goetz CG, Thelen JA, MacLeod CM, Carvey PM, Bartley EA, Stebbins GT. Blood levodopa levels and unified Parkinson's disease rating scale function: with and without exercise. Neurology. 1993 May; 43(5):1040-2. PMID: 8492923.
      View in: PubMed
    76. Carvey PM, Ptak LR, Nath ST, Sierens DK, Mufson EJ, Goetz CG, Klawans HL. Striatal extracts from patients with Parkinson's disease promote dopamine neuron growth in mesencephalic cultures. Exp Neurol. 1993 Mar; 120(1):149-52. PMID: 8097475.
      View in: PubMed
    77. Kerns JM, Sierens DK, Kao LC, Klawans HL, Carvey PM. Synaptic plasticity in the rat striatum following chronic haloperidol treatment. Clin Neuropharmacol. 1992 Dec; 15(6):488-500. PMID: 1335837.
      View in: PubMed
    78. Carvey PM, Ptak LR, Lo ES, Lin DH, Buhrfiend CM, Goetz CG, Klawans HL. Levodopa reduces the growth promoting effects of striatal extracts on rostral mesencephalic tegmentum cultures. Exp Neurol. 1991 Oct; 114(1):28-34. PMID: 1915732.
      View in: PubMed
    79. Carvey PM, McRae A, Lint TF, Ptak LR, Lo ES, Goetz CG, Klawans HL. The potential use of a dopamine neuron antibody and a striatal-derived neurotrophic factor as diagnostic markers in Parkinson's disease. Neurology. 1991 May; 41(5 Suppl 2):53-8; discussion 59-60. PMID: 2041594.
      View in: PubMed
    80. Shults CW, O'Connor DT, Baird A, Hill R, Goetz CG, Watts RL, Klawans HL, Carvey PM, Bakay RA, Gage FH, et al. Clinical improvement in parkinsonian patients undergoing adrenal to caudate transplantation is not reflected by chromogranin A or basic fibroblast growth factor in ventricular fluid. Exp Neurol. 1991 Mar; 111(3):276-81. PMID: 1999231.
      View in: PubMed
    81. Kroin JS, Kao LC, Zhang TJ, Penn RD, Klawans HL, Carvey PM. Dopamine distribution and behavioral alterations resulting from dopamine infusion into the brain of the lesioned rat. J Neurosurg. 1991 Jan; 74(1):105-11. PMID: 1984488.
      View in: PubMed
    82. Carvey PM, Nath ST, Kao LC, Zhang TJ, Lin DH, Singh R, Amdur RL, Klawans HL. Clozapine fails to prevent the development of haloperidol-induced behavioral hypersensitivity in a cotreatment paradigm. Eur J Pharmacol. 1990 Aug 02; 184(1):43-53. PMID: 2209714.
      View in: PubMed
    83. Carvey PM, Kao LC, Zhang TJ, Amdur RL, Lin DH, Singh R, Klawans HL. Dopaminergic alterations in cotreatments attenuating haloperidol-induced hypersensitivity. Pharmacol Biochem Behav. 1990 Feb; 35(2):291-300. PMID: 2320636.
      View in: PubMed
    84. Dahlström A, Wigander A, Lundmark K, Gottfries CG, Carvey PM, McRae A. Investigations on auto-antibodies in Alzheimer's and Parkinson's diseases, using defined neuronal cultures. J Neural Transm Suppl. 1990; 29:195-206. PMID: 2358801.
      View in: PubMed
    85. Carvey PM, McRae A, Ptak LR, Kao LC, Lo ES, Goetz CG, Tanner CM, Penn RD, Klawans HL. Disappearance of a putative DA-neuron antibody following adrenal medulla transplantation: relationship to a striatal-derived DA neuron trophic factor. Prog Brain Res. 1990; 82:693-7. PMID: 2290972.
      View in: PubMed
    86. Carvey PM, Ptak LR, Kao L, Klawans HL. Striatal homogenates from animals chronically treated with haloperidol stimulate dopamine and GABA uptake in cultures of rostral mesencephalic tegmentum. Clin Neuropharmacol. 1989 Oct; 12(5):425-34. PMID: 2611766.
      View in: PubMed
    87. Carvey P, Nausieda P, Weertz R, Klawans H. LSD and other related hallucinogens elicit myoclonic jumping behavior in the guinea pig. Prog Neuropsychopharmacol Biol Psychiatry. 1989; 13(1-2):199-210. PMID: 2748860.
      View in: PubMed
    88. McRae-Degueurce A, Klawans HL, Penn RD, Dahlstrom A, Tanner CM, Goetz CG, Carvey PM. An antibody in the CSF of Parkinson's disease patients disappears following adrenal medulla transplantation. Neurosci Lett. 1988 Nov 22; 94(1-2):192-7. PMID: 3241668.
      View in: PubMed
    89. Goetz CG, Tanner CM, Shannon KM, Carroll VS, Klawans HL, Carvey PM, Gilley D. Controlled-release carbidopa/levodopa (CR4-Sinemet) in Parkinson's disease patients with and without motor fluctuations. Neurology. 1988 Jul; 38(7):1143-6. PMID: 3290706.
      View in: PubMed
    90. Carvey PM, Hitri A, Goetz CG, Tanner CM, Klawans HL. Concurrent treatment with benztropine and haloperidol attenuates development of behavioral hypersensitivity but not dopamine receptor proliferation. Life Sci. 1988; 42(22):2207-15. PMID: 3374255.
      View in: PubMed
    91. Carvey PM, Braun AR, Kao LC, Klawans HL. Effects of dopamine antagonists and apomorphine on regional energy metabolism in rat CNS. Clin Neuropharmacol. 1987 Jun; 10(3):247-60. PMID: 3454716.
      View in: PubMed
    92. Carvey PM, Kao LC, Klawans HL. The effect of bilateral kainic acid-induced lateral habenula lesions on dopamine-mediated behaviors. Brain Res. 1987 Apr 14; 409(1):193-6. PMID: 3580867.
      View in: PubMed
    93. Klawans HL, Carvey PM, Nelson D, Tanner CM, Goetz CG. The effect of thioridazine on haloperidol induced behavioral hypersensitivity. Life Sci. 1986 May 12; 38(19):1707-14. PMID: 3702600.
      View in: PubMed
    94. Carvey PM, Kao LC, Tanner CM, Goetz CG, Klawans HL. The effect of antimuscarinic agents on haloperidol induced behavioral hypersensitivity. Eur J Pharmacol. 1986 Jan 21; 120(2):193-9. PMID: 3948919.
      View in: PubMed
    95. Klawans HL, Carvey PM, Tanner CM, Goetz CG. Drug-induced myoclonus. Adv Neurol. 1986; 43:251-64. PMID: 3484854.
      View in: PubMed
    96. Carvey P, Paulseth JE, Goetz CG, Klawans HL. L-5-HTP-induced myoclonic jumping behavior in guinea pigs: an update. Adv Neurol. 1986; 43:509-17. PMID: 3484857.
      View in: PubMed
    97. Klawans HL, Carvey P, Tanner CM, Goetz CG. The pathophysiology of tardive dyskinesia. J Clin Psychiatry. 1985 Apr; 46(4 Pt 2):38-41. PMID: 2858479.
      View in: PubMed
    98. Goetz CG, Carvey PM, Tanner CM, Klawans HL. Neuroleptic-induced dopamine hyposensitivity. Life Sci. 1984 Apr 09; 34(15):1475-9. PMID: 6538629.
      View in: PubMed
    99. Klawans HL, Goetz CG, Carvey P. Animal models of tardive dyskinesias. Clin Neuropharmacol. 1983 Jun; 6(2):129-35. PMID: 6133617.
      View in: PubMed
    100. Goetz CG, Klawans HL, Carvey P. Animal models of tardive dyskinesia: their use in the search for new treatment methods. Mod Probl Pharmacopsychiatry. 1983; 21:5-20. PMID: 6140633.
      View in: PubMed
    101. Nausieda PA, Carvey PM, Braun A. Long-term suppression of central serotonergic activity by corticosteroids: a possible model of steroid-responsive myoclonic disorders. Neurology. 1982 Jul; 32(7):772-5. PMID: 6979722.
      View in: PubMed
    102. Nausieda PA, Carvey PM, Weiner WJ. Modification of central serotonergic and dopaminergic behaviors in the course of chronic corticosteroid administration. Eur J Pharmacol. 1982 Mar 12; 78(3):335-43. PMID: 6978254.
      View in: PubMed
    103. Weiner WJ, Carvey P, Nausieda PA, Goetz CG, Klawans HL. Effect of chronic levodopa on haloperidol-induced behavioral supersensitivity in the guinea pig. Adv Neurol. 1982; 35:213-9. PMID: 6890754.
      View in: PubMed
    104. Weiner WJ, Carvey P, Nausieda PA, Goetz CG, Klawans HL. The effect of chronic levodopa on haloperidol induced behavioral supersensitivity in the guinea pig. Life Sci. 1981 May 11; 28(19):2173-8. PMID: 7195969.
      View in: PubMed
    105. Klawans HL, Carvey P, Hitri A, Nausieda PA, Weiner WJ. Correlation between daily dosage of chlorpromazine and subsequent supersensitivity. Adv Biochem Psychopharmacol. 1980; 24:569-72. PMID: 7190763.
      View in: PubMed
    106. Weiner WJ, Carvey PM, Nausieda PA, Klawans HL. Dopaminergic antagonism of L-5-hydroxytryptophan-induced myoclonic jumping behavior. Neurology. 1979 Dec; 29(12):1622-5. PMID: 41197.
      View in: PubMed
    Carvey's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    See all (425) concept(s)
    _
    Co-Authors Expand Description
    See all (14) people
    _
    Similar People Expand Description
    See all (60) people
    _
    Same Department Expand Description
    Search Department
    Physical Neighbors Expand Description
    _